Clinical Trial Update: Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum [Phase 2, Phase 3]

View source ↗

Summary

This update reports the results of Phase 2 and Phase 3 trials evaluating the efficacy and tolerability of topical potassium hydroxide at 10% and 15% in Molluscu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Molluscum Contagiosum

Drugs mentioned

• Potassium hydroxide 10% (potassium hydroxide)
• Potassium hydroxide 15% (potassium hydroxide)

Snippet

Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | Conditions: Molluscum Contagiosum | Phase 2, Phase 3 | Status: COMPLETED